Skip to main content Skip to main content
Go to homepage

The CARRA Registry for Pediatric Rheumatic Diseases

The CARRA Registry for Pediatric Rheumatic Diseases


The CARRA Registry will help monitor the long term safety of current medications being used to treat pediatric rheumatic diseases. By collecting information from thousands of patients to evaluate their treatments, side effects and quality of life.

Learn more here.

Who May Qualify?:

Children and young adults with pediatric rheumatic disease from 2 to 21 years of age.

Who Does Not Qualify:

Patients over 21 years of age.

Interested in participating?
We are currently recruiting
Study Sponsor:

Duke University

Full IRB Study Title:
Observational Study Of Pediatric Rheumatic Diseases: The CARRA Registry
IRB Study ID:
If you are interested in this study or have questions about your child's eligibility, please contact:

Sherry Hillyer, Clinical Research Nurse: 330-543-5853

Jessica Kracker, Clinical Research Nurse: 330-543-0846

Lead Investigator
Kathryn Cook, DO

Director, Division of Rheumatology; Pediatric Rheumatologist
Pediatric RheumatologyVasculitis Clinic

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.